Nov 2, 2017 | By Tess

Philadelphia-based 3D bioprinter developer BioBots has announced it is rebranding itself under the company name Allevi. In addition to the new name, the startup has launched a new bioprinting software which it says will enable scientists and tissue engineers to work more easily with their bioprinters.

Allevi (formerly BioBots) was founded in 2014 by University of Pennsylvania graduates Ricardo Solorzano and Daniel Cabrera. At the time, the ambitious duo set out to develop an accessible desktop bioprinting system which could be used for a wide variety of research and educational applications.

Now, three years on, the company is now looking to expand their scope with 3D bioprinting software.

Allevi2 3D bioprinter

“Four years ago, no one knew what to do with a 3D bioprinter, a user would have to train for months on end to get the basics, and units were only accessible to a handful of researchers,” said Solorzano. “We designed the first ever desktop 3D bioprinter and brought that to hundreds of scientists around the world.”

“We have accomplished a lot as a hardware company, but our name change has been inspired by our desire to grow our product offering past 3D bioprinters to include an entire suite of biofabrication tools.”

Allevi’s bioprinting software program is aimed at ease-of-use above all. As the company explains in a release, existing bioprinting software is often very complicated and requires a high learning curve. This, of course, is suitable for certain research applications, but Allevi believes that bioprinting shouldn’t just be for the upper echelons of science.

The new software program therefore offers a number of features, including an integrated slicer which ensures standardization; a projects feature which enables users to save digital printing profiles and protocols, making it easy to replicate experiments and settings; and well categorization, which allows users to “vary settings within a well plate to test multiple parameters within the same experiment.”

All of these tools, combined with a user-friendly interface, are aimed at making Allevi’s bioprinting process more accessible.

Allevi6 3D bioprinter

“Tissue engineers know what they want to design,” Solorzano added. “They understand how tissue are suppose to look and behave…They haven’t known how to bring these designs to life though.”

“Our new software helps you control the parameters for the optimum print. It’s through a process of iteration and data aggregation that are we able to recognize patterns, make conclusion, and set up models to allow predictability. We want to make it easier to see these patterns.”

At the moment, Allevi has made its bioprinting software available to beta users, and plans to roll out more software testing labs soon. The software program is, of course, compatible with the company’s Allevi2 desktop bioprinter and its more “robust” Allevi6 bioprinter models.

Solorzano concluded the announcement by saying: “As we look toward to the future, we look towards creating biofabrication platforms that can have a huge impact in the clinical and pharmaceutical worlds. We want to be able to take those things that are most valuable from the lab and bring them to the industry to change the way we think about and develop medicine.”



Posted in 3D Printer Company



Maybe you also like:


Leave a comment:

Your Name:


Subscribe us to Feeds twitter facebook   

About provides the latest news about 3D printing technology and 3D printers. We are now seven years old and have around 1.5 million unique visitors per month.

News Archive